Zoltan Banki
0000-0002-3826-5800
5 papers found
Refreshing results…
Six-Month Follow-Up of Immune Responses after a Rapid Mass Vaccination against SARS-CoV-2 with BNT162b2 in the District of Schwaz/Austria
Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial
N-chlorotaurine is highly active against respiratory viruses including SARS-CoV-2 (COVID-19) in vitro
Persistence of immunity to SARS-CoV-2 over time in the ski resort Ischgl
Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment
Missing publications? Search for publications with a matching author name.